title: Glucose-to-insulin ratio in intravenous tolbutamide test predicts long-term therapeutic outcome in NIDDM.
authors.forename: N
authors.initials: N
authors.lastname: Takeda
authors.forename: K
authors.initials: K
authors.lastname: Yasuda
authors.forename: T
authors.initials: T
authors.lastname: Horiya
authors.forename: S
authors.initials: S
authors.lastname: Goto
authors.forename: M
authors.initials: M
authors.lastname: Hayashi
authors.forename: Y
authors.initials: Y
authors.lastname: Ito
authors.forename: K
authors.initials: K
authors.lastname: Aoyama
authors.forename: K
authors.initials: K
authors.lastname: Miura
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007328:Insulin / Q000097:blood*; D011379:Prognosis; D014044:Tolbutamide / Q000627:therapeutic use
chemical_list: D001786:Blood Glucose; D007328:Insulin; D014044:Tolbutamide